Flumatinib (Compound)

Compound:

flumatinib (f343d257-51e3-4492-870b-ea1c82e0d482)

Synonyms:Flumatinib, 895519-90-1, HHGV678, HH-GV678, Flumatinib free base, UNII-R4009Y24AI, HHGV-678, R4009Y24AI, 895519-90-1 (free base), 4-[(4-methylpiperazin-1-yl)methyl]-N-[6-methyl-5-[(4-pyridin-3-ylpyrimidin-2-yl)amino]pyridin-3-yl]-3-(trifluoromethyl)benzamide, HHGV678 mesylate, BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-, N-(6-methyl-5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)pyridin-3-yl)-4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamide, HH-GV-678, flumbatinib, Hansoh Xinfu, flumatinib (pseudo INN), GTPL9913, SCHEMBL4883843, CHEMBL3545413, DTXSID60237779, BCP23797, EX-A3572, VKB51990, BDBM50529313, NSC830368, ZINC68244727, CS-5550, DB11904, NSC-830368, SB17192, NCGC00378614-01, 4-(4-Methylpiperazin-1-ylmethyl)-N-(6-methyl-5-(4-pyridin-3-ylpyrimidin-2-ylamino)pyridin-3-yl)-3-trifluoromethylbenzamide, DA-33625, HY-13904, FT-0739882, Q27287759, N-[5-[[4-(3-Pyridinyl)pyrimidine-2-yl]amino]-6-methylpyridine-3-yl]-3-(trifluoromethyl)-4-[(4-methylpiperazine-1-yl)methyl]benzamide

Pubchem:PUBCHEM:46848036

Id:46848036

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Flumatinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Flumatinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Flumatinib.

Results found

Linked to

	Label	Description
	flumatinib positively regulates LPAR6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib negatively regulates SERPINA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib negatively regulates CCL20 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib positively regulates RPS4Y1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib positively regulates TMT1A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib positively regulates ABCC4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib positively regulates INSIG1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib positively regulates BICC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	flumatinib positively regulates MSMO1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	nintedanib in similarity relationship with flumatinib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS